Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Key information regarding dividend for Norway Royal Salmon (NRS)

Dividend amount: 10.00 per share. Distributed by way of cash dividend of 7.50 per share and distribution of shares in NRS from the company’s treasury shares. Declared currency: NOK Last day including right:  4 June 2020 Ex-date: 5 June 2020 Record date: 8 June 2020 Payment date: on or around 15 June 2020 Date of approval: 4 June 2020 Other information: The number of shares for distribution in total and per outstanding share will be decided based on the shares' volume weighted average price on the Oslo Stock Exchange five trading days before the general meeting, and will

Invitation to Presentation of Promore Pharma’s Year-end report for 2019

STOCKHOLM, 13 February 2020 – Promore Pharma AB (publ) publishes its Year-end report for 2019 at 16.00 CET on 18 February 2020.The next day, 19 February, the company will host a webcast telephone conference at 09.00 CET, with President and CEO Jonas Ekblom and CFO Jenni Björnulfson. After the presentation there will be a Q&A session. The presentation will be held in English. The conference can be accessed via computer, tablet or telephone. To join the web conference, please use the following link: https://global.gotomeeting.com/join/490242685 To join the telephone conference, please

New study: Brain-friendly diet supports the vitality and well-being of office workers

A brain-friendly diet has a positive impact on cognitive performance and alertness, as well as improving cardiovascular health, reveals a recent study. Fazer, Nokia, Nightingale Health and the Finnish Institute of Occupational Health investigated the impacts of a brain-friendly diet on the well-being of office workers. The results of this internationally published research were introduced to Finnish media and nutrition specialists on February 13 in Helsinki.Today’s working life is tough on the brain. Fast-paced surroundings, constantly changing stimuli, and always-on working practices that

Popular village pub is saved after family-owned Lakeland Inns adds it to portfolio

History of the Royal Oak can be traced back to late 1700sA FAMILY-owned pub and brewery chain is celebrating after adding a popular local to its portfolio of properties. Lakeland Inns has snapped up The Royal Oak which sits alongside the River Crake in Spark Bridge, a village in the Lake District National Park. The pub has been closed more recently, but will reopen later this month after a mini revamp serving a wide selection of wines, spirits and locally brewed ales.  From the kitchens, a team will create gastropub-style dishes with all fresh ingredients sourced from within 20

Vattenfall and Deutsche Telekom subsidiary sign long-term solar power agreement

Vattenfall and the Deutsche Telekom subsidiary Power & Air Solutions have signed a 10-year supply contract for electricity from a new German solar park.Vattenfall and the Deutsche Telekom subsidiary Power & Air Solutions have signed an energy supply contract (Corporate Power Purchase Agreement, CPPA) based on solar power with a term of ten years. The renewable electricity comes from a new solar park, which will be built by the customer in Mecklenburg-Western Pomerania in mid-2021. The plant will have an installed capacity of 60 megawatts (MW).  “We are very pleased that with this

Proposal by the Nomination Committee of AQ Group AB for election of members of the Board of Directors

AQ Group's Nomination Committee consists of Per-Olof Andersson, Claes Mellgren, Björn Henriksson, representing Nordea Fonder, and the Chairman of the Nomination Committee Vegard Søraunet, representing ODIN Fonder. In accordance with the Annual General Meeting's decision, the Nomination Committee shall evaluate the composition and work of the Board and prepare proposals for the 2020 Annual General Meeting. The Nomination Committee has evaluated the work of the Board and the Chairman of the Board has described how the work has been conducted. The Nomination Committee has also supplemented

AcuCort confirms response from the Swedish MPA regarding ISICORT® market application

AcuCort AB (Spotlight Stock Market: ACUC) has received the Primary Round Assessment Report from the Swedish Medical Products Agency (MPA), in response to the national Market Authorization Application (MAA) for ISICORT® in September 2019. The company is currently reviewing the report and preparing answers. No significant obstacles have been identified. No major objections towards an approval have been raised by the MPA.As reported on September 30[th] 2019, AcuCort AB has submitted a national hybrid application for approval of the company’s drug candidate ISICORT® to the Swedish Medical

More IT brands focus on sustainability to meet strict criteria in TCO Certified

Purchasers increasingly include sustainability criteria in procurement. It motivates the IT industry to prioritize sustainability issues and the brands Ciara and Inforlandia are the latest to make adjustments to their production to meet the strict criteria in TCO Certified.Canadian public agencies have used TCO Certified in procurement for more than 20 years and in 2018, the Canadian Government announced that it would include additional product categories in their TCO Certified requirement. This led Ciara to apply for TCO Certified for its systems destined to the Canadian Government.

Finnair adding extra frequencies to New York JFK airport for summer 2020 season

Finnair is adding additional frequencies to its popular New York JFK route for the upcoming summer 2020 season. Between April 4 and October 24, Finnair will operate three additional weekly frequencies on Mondays, Thursdays and Saturdays. Between May 4 and October 24, a fourth additional frequency will be added on Tuesdays. Furthermore, a fifth additional frequency will be flown on Sundays for the peak summer season between June 8 and August 30.   Finnair has flown to New York for over 50 years and currently flies daily flights to JFK airport. With these new frequencies, Finnair is adding

Ahlstrom-Munksjö to repurchase own shares

AHLSTROM-MUNKSJÖ OYJ STOCK EXCHANGE RELEASE FEBRUARY 13, 2020 at 10:00 a.m. EET  The Board of Directors of Ahlstrom-Munksjö Oyj has decided to utilize the current authorization given by the Annual General Meeting (AGM) held on March 27, 2019 to repurchase own shares. The authorization, to acquire a maximum of 11,500,000 of the company's own shares, is valid until the end of the AGM 2020 to be held on March 25, 2020. The repurchases will start at the earliest on February 18, 2020 and end on March 24, 2020 at the latest. The amount of shares to be acquired shall not exceed 300,000

Mandatory Notification of Trade - Options

Reference is made to the announcement on 5 April, 2017, in which Hexagon Composites ASA (the "Company") announced the grant of 1,640,000 share options to employees under its employee share option program, each at a strike price of NOK 27 per share. Of the 1,640,000 options, 1,175,000 options were granted to senior executives and managers listed as primary insiders. The options may be exercised in part or in full within three weeks following the official announcement of the financial results for the fourth quarter of 2019, first quarter of 2020 and second quarter of 2020. Primary

CLINE SCIENTIFIC HAS STARTED TESTING THEIR DIAGNOSTIC PROTOTYPE FOR METASTASIZING CANCERS ON LIVE PATIENT MATERIAL WITH CLINICAL RESEARCHERS AT A SWEDISH HOSPITAL

Gothenburg, Sweden (February 13 2020):  Cline Scientific will have begun to utilize live tumor cells directly from cancer patients to develop and test their diagnostic prototype for metastasizing cancers to bring this technology to marketThe tumor cells originate from biopsies taken from patients with benign or metastatic tumors. Cline’s prototype has shown promising results in differentiating metastatic from benign tumor cells. Testing on live patient material is a necessary technical step to test how cells from patient biopsies behave before the company is able to initiate clinical

New plan periods in the share-based long-term plans and a new matching share plan for Ahlstrom-Munksjö

AHLSTROM-MUNKSJÖ OYJ STOCK EXCHANGE RELEASE February 13, 2020, at 9:45 a.m. EET Ahlstrom-Munksjö's Board of Directors has decided on a new performance period under the long-term share-based incentive plan announced on October 24, 2017. The Board of Directors has, in addition, decided on the establishment of a fixed matching share plan as well as on the establishment of a new earning period in the restricted share plan that was announced in March 28, 2019. The aim of the plans is to align the objectives of the company's shareholders and key personnel to increase the company's value and to

ENDOMINES Year-end report 2019 Ramp-up of Friday continued succesfully

Endomines AB, Stock Exchange Release 13 February 2020 at 08:30 CET Full year 2019 (vs. Full year 2018) Operational highlights · Friday Orogrande processing facility successfully commissioned · Taking over full operational control of the Friday Underground mining activities succesfully completed · No injuries reported in the last 12 months; LTIFR 0 (11) Financial highlights · Total revenue was 5.8 MSEK (105.3) · EBITDA was –48.8 MSEK (-5.5) · Total cash flow was -3.3 MSEK (0.4) · Earnings per share was -1.28 SEK (-1.01) Significant subsequent events ·

ColdZyme – third largest cold brand in Sweden

Q4 · Net sales reached SEK 22.2 (18.9) million. · Result after tax came in at SEK -5.3 (-7.4) million. · Earnings per share, basic and diluted, were SEK -0.04 (-0.07). · Cash and cash equivalents were SEK 29.3 (70.3) million.  Significant events during the quarter · After ending the year on a strong note, ColdZyme® surpassed Nipaxon and became the third largest cold brand in terms of sales value from pharmacies in the Swedish market, with a market share of 6.5%. In the fourth quarter, sales of ColdZyme to consu-mers increased by 7%, compared with market growth for

Pharmacolog's Year-end Bulletin 2019

Press release: Uppsala, February 13, 2020. Pharmacolog i Uppsala AB’s (publ) Year-end Bulletin 2019 is now available on the company’s webbsite www.pharmacolog.com (Swedish only)Fjärde kvartalet 1 oktober 2019 – 31 december 2019  ·Bolagets nettoomsättning för perioden uppgick till 61 (771)Tkr. ·Rörelseresultatet för perioden uppgick till -4 627 (-3 239) Tkr. ·Nettoresultat per aktie före och efter utspädning var för perioden -0,59 (-0,46) kr. Perioden 1 januari 2019 – 31 december 2019  ·Bolagets nettoomsättning för perioden uppgick till 2 182 (1 035)Tkr. ·

Swedencare AB (publ) YEAREND REPORT OCTOBER 1st – DECEMBER 31st 2019

Once again a strong year for Swedencare!SUMMARY OF THE PERIOD FOURTH QUARTER: OCTOBER 1ST – DECEMBER 31ST 2019 Numbers in parentheses refers to outcomes during the corresponding period of the previous year. · Net revenue amounted to 34,084 KSEK (27,778 KSEK), an increase of 23% · Organic, currency-adjusted growth amounted to 13% · Operating profit before depreciation (EBITDA) amounted to 8,246 KSEK (7,684 KSEK), correspondingto an increase of 7% and an EBITDA margin of 24,2% (27.7%) · Operating profit after depreciation (EBIT) amounted to 6,584 KSEK (7,332 KSEK),

Wärtsilä gas power plant will facilitate growth of Bangladeshi industrial complex

Wärtsilä Corporation, Press release, 13 February 2020 at 9.30 am EETThe technology group Wärtsilä has been awarded to supply a 78 MW engine power plant on a fast-track basis in order to support the growth of an industrial complex in Bangladesh. The order was placed in November by Jamuna Power, a part of the Jamuna Group, one of Bangladesh’s largest industrial conglomerates. The plant will be installed at the Jamuna Industrial Park project in the northeastern part of the country, and it will operate on eight Wärtsilä 34SG engines fueled by gas. The industrial park is currently operating

Viking Supply Ships AB (publ) Year-end report 2019

Press release  13 February 2020The financial net result improved by MSEK 178 from MSEK (-123) in the corresponding period in 2018 to MSEK 55 in the fourth quarter of 2019. Revenue increased to MSEK 156 (52) for the quarter, which was in line with the previous quarter. EBITDA is positive for the quarter at MSEK 63 (-51). For the full year 2019, revenue from continuing operations was MSEK 504, which is a significant improvement of the corresponding figure for 2018 (300). EBITDA for the full year 2019 was MSEK 114, while the net result was MSEK 52. Both EBITDA and net result are significant

MEDIVIR AB – YEAR END REPORT JANUARY – DECEMBER 2019

Continued progress with our proprietary and wholly owned candidate drug MIV-818 for liver cancer October – DecemberSignificant events during the quarter · Preclinical data showing that in addition to its direct effect on cancer cells, MIV-818 also modulates the anti-tumor immune response, presented at the AACR-NCI-EORTC conference in Boston. · The ninth and final liver cancer patient was included in the phase Ia study with MIV-818. Based on safety and tolerability as well as pharmaco-kinetics and positive biomarker data, it was decided to initiate the phase Ib part of the study.

Stora Enso’s Annual Report 2019 published

STORA ENSO OYJ ANNUAL FINANCIAL REPORT 13 February 2020 at 9.30 EET Stora Enso’s Annual Report 2019 has been published at storaenso.com/annualreport . The Annual Report 2019 consists of four sections: Strategy, Sustainability, Financials and Governance. Strategy explains how our transformation is progressing and how we create value as a renewable materials company, highlighting key events from all divisions. Sustainability covers Stora Enso’s social, environmental, and economic sustainability performance. Financials consists of the report of

NRC Group ASA: Key information relating to subsequent offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANYOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange published by NRC Group ASA (the "Company") on 12 February 2020, regarding a private placement of 18,918,919 new shares in the Company (the "Private Placement") and a subsequent offering of up to 1,891,892 new shares at the same

The Nomination Committee's proposal regarding the Board of Humana for the 2020 AGM

Ahead of the Annual General Meeting 2020 the Nomination Committee of Humana AB has decided to propose Karita Bekkemellem and Anders Nyberg as new directors of the Board.The Nomination Committee proposes that the Board be composed of seven directors (unchanged from the current year) elected at the Annual General Meeting, with no alternates, for the period until the next Annual General Meeting The Nomination Committee proposes re-election of Magdalena Gerger, Kirsi Komi, Monica Lingegård, Sören Mellstig and Fredrik Strömholm as directors and election of Karita Bekkemellem and Anders Nyberg

There are no items matching the current filter
There are no more items matching the current filter
Back to top